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Abstract
 
The Fc
 
g 
 
receptor (Fc
 
g
 
R)-mediated phagocytosis of macrophages is a complex process where
remodeling of both the actin-based cytoskeleton and plasma membrane occur coordinately.
Several different families of small GTPases are involved. We have isolated a GTPase-activating
protein (GAP) for ADP-ribosylation factor (ARF), paxillin-associated protein with ARFGAP
activity (PAG)3/Pap
 
a
 
/KIAA0400, from mature monocytes and macrophage-like cells. Mam-
malian ARFs fall into three classes, and the class III isoform (ARF6) has been shown to be in-
volved in Fc
 
g
 
R-mediated phagocytosis. Here we report that PAG3 is enriched together with
ARF6 and F-actin at phagocytic cups formed beneath immunoglobulin G–opsonized beads in
P388D1 macrophages, in which overexpression of ARF6, but not ARF1 (class I) or ARF5
(class II), inhibits the phagocytosis. Overexpression of PAG3, but not its GAP-inactive mutant,
attenuated the focal accumulation of F-actin and blocked phagocytosis, although surface levels
of the Fc
 
g
 
Rs were not affected. Other ubiquitously expressed ARFGAPs, G protein–coupled
receptor kinase interactors GIT2 and GIT2-short/KIAA0148, which we have shown to ex-
hibit GAP activity for ARF1 in COS-7 cells, did not accumulate at the phagocytic cups or in-
hibit phagocytosis. Moreover, cooverexpression of ARF6, but not ARF1 or ARF5, restored
the phagocytic activity of PAG3-overexpressing cells. We propose that PAG3 acts as a GAP for
ARF6 and is hence involved in Fc
 
g
 
R-mediated phagocytosis in mouse macrophages.
Key words: actin remodeling • ARF family GTPases • ARFGAP • membrane remodeling • 
Rho family GTPases
 
Introduction
 
During Fc
 
g 
 
receptor (Fc
 
g
 
R)-mediated phagocytosis, re-
modeling of actin-based cytoskeletal organization and re-
modeling of plasma membrane structure should be coordi-
nately regulated near and at the phagocytic cups (1, 2).
Processes for phagocytosis involve accumulation of F-actin
beneath bound particles and their dynamic remodeling con-
forming to the cytoarchitecture of phagocytic cups during
engulfment of the particles (3). Engulfment of even large
numbers of particles by macrophages is not accompanied by
an apparent reduction in surface area, indicating that mem-
brane components are supplied during phagocytosis, possi-
bly by exocytosis of intracellular vesicles or endosomal
membrane (2, 4, 5). In accordance with the complex pro-
cesses of Fc
 
g
 
R-mediated phagocytosis, several distinct fam-
ilies of Ras superfamily small GTPases have been shown to
be involved. Inhibition of Cdc42 and Rac1 has been
shown, by expression of dominant negative mutants, to in-
hibit Fc
 
g
 
R-mediated phagocytosis by preventing the accu-
mulation of F-actin at the phagocytic cup, though it does
not affect particle binding to Fc
 
g
 
Rs (6–8). Involvement of
Rho in Fc
 
g
 
R-mediated phagocytosis is controversial. It has
 
been shown that inhibition of RhoA by injection of C3 exo-
toxin inhibits Fc
 
g
 
R-mediated phagocytosis by preventing
 
the accumulation of F-actin beneath bound particles and
receptor clustering in J774 macrophages as well as blocking
Fc
 
g
 
R-mediated phagocytosis in Fc
 
g
 
RIIA-transfected COS
cells (9). On the other hand, recent studies suggest that
Fc
 
g
 
R-mediated phagocytosis in J774 macrophages may be
independent of RhoA function (7, 8).
 
Address correspondence to Hisataka Sabe, Department of Molecular Bi-
ology, Osaka Bioscience Institute, 6-2-4 Furuedai, Suita, Osaka 565-
0874, Japan. Phone: 81-6-6872-4814; Fax: 81-6-6871-6686; E-mail:
sabe@obi.or.jp 
956
 
PAG3 Regulates ADP-Ribosylation Factor 6 in Macrophage Phagocytosis
 
ADP-ribosylation factor (ARF)
 
1
 
 6 , an isoform of the
ARF family GTPases that also belong to Ras superfamily
small GTPases, has also been shown to be involved in the
phagocytosis (10). ARFs were originally identified and
named for their ability to serve as cofactors in the cholera
toxin–catalyzed ADP-ribosylation of the 
 
a
 
 subunit of Gs
(11) and have been shown to function in various mem-
brane trafficking events and in the maintenance of or-
ganelle structure (12, 13). Members of the family include
six isoforms of ARF, and the ARF-like proteins in mam-
malian cells (14, 15). The six ARF isoforms are highly ho-
mologous to one another and are classified as class I, II, or
III based on sequence similarity (14). Class I includes
ARF1, 2, and 3, class II includes ARF4 and 5, and class III
includes ARF6. Among them, ARF1 has been most thor-
oughly studied and has been shown to regulate membrane
traffic at multiple sites within the cell, such as endoplasmic
reticulum–to-Golgi transport, and to activate phospho-
lipase D (16). The GTP-bound form of ARF1 recruits
protein coats, including the clathrin-associated adaptor
proteins and the nonclathrin coatomers, to the donor
membrane and initiates budding of the membrane to form
vesicles; subsequent hydrolysis of the bound GTP to GDP
at the target membrane appears to trigger disassembly of the
coat from the vesicle, which is necessary for the vesicle to
fuse to the target membrane (13, 16). On the other hand,
ARF6, the ARF which is most distantly related to ARF1,
shows a rather wide distribution in the cytoplasm and local-
izes to an endosomal compartment and membrane ruffling
regions. It has been shown to regulate endosomal traffick-
ing and receptor-mediated endocytosis at the cell periph-
ery, recycling of endosomal vesicles to the plasma mem-
brane, actin rearrangements beneath the plasma membrane,
and cell spreading (13, 17–25). ARF6 appears to cycle be-
tween the plasma membrane and the recycling endosomes,
depending on its nucleotide status; it has been shown that
the GTP hydrolysis-defective mutant of ARF6 accumulates
at the plasma membrane, and that the GTP binding defec-
tive mutant of ARF6 localizes to the recycling endosomes
(20). The function of the class II ARFs and the ARF-like
proteins is not yet clear. It is noteworthy that, unlike other
small GTPase family proteins such as Ras family and Rho
family proteins, the intrinsic GTPase activity of ARF pro-
teins is almost undetectable in vitro (11); thus, GTPase-
activating proteins (GAPs) appear to be essential for ARFs
in their transition from the GTP-bound form to the GDP-
bound form.
The involvement of ARF6 in Fc
 
g
 
R-mediated macro-
phage phagocytosis has been demonstrated (10). In this
case, both types of ARF6 mutants, one defective in GTP
hydrolysis (Q67L) and the other defective in GTP binding
(T27N), have been shown to inhibit phagocytosis of IgG-
coated erythrocytes and to attenuate the focal accumulation
 
of F-actin beneath the test particles in mouse RAW 264.7
macrophages (hereafter called RAW). Moreover, overex-
pression of wild-type ARF6 can also exert inhibitory ef-
fects on Fc
 
g
 
R-mediated phagocytosis (10). On the other
hand, it has been also shown that brief treatment (30-min
incubation) of macrophage cells with brefeldin A (BFA)
does not affect phagocytosis, although the organization and
function of the Golgi apparatus in the BFA-treated cells
was disrupted (10). BFA is known to inhibit activities of
several nucleotide exchanging factors for ARFs and hence
inhibits the function of ARFs, with the exception of ARF6
(12, 18, 26, 27). Thus, BFA-sensitive ARF isoforms ap-
peared to be nonessential for the phagocytosis (10).
It has recently been shown in several types of cells, such
as HeLa, Swiss 3T3, and NRK cells, that actin cytoskeletal
structure and membrane structure are regulated as a conse-
quence of intercommunication between Rho family GTP-
ases and ARF family GTPases (22, 28, 29). In RAW mac-
rophage cells, Rac1-mediated membrane ruffling and actin
polymerization have been shown to require the participa-
tion of ARF6 (23). Therefore, it is likely that intercommu-
nication between Rho and ARF family GTPases also plays
an essential role during phagocytosis, for the coordinated
regulation of remodeling of actin-based cytoskeletal orga-
nization, remodeling of plasma membrane structure, and
receptor trafficking as well (1, 2). Moreover, it should be
also noted that both Rac1 and ARF6 also participate in the
activation of phagocyte NADPH oxidase (30, 31).
We have isolated a GAP for ARF, paxillin-associated
protein with ARFGAP activity (PAG)3, from mature
monocytes and macrophage-like cells, as a binding protein
of paxillin (32). Paxillin is one of the integrin assembly fo-
cal adhesion proteins and also exists at Fc
 
g
 
R-mediated
phagocytic cups in macrophages (33, 34). PAG3 is induced
to be expressed on monocyte maturation and localizes to
the cell periphery, together with paxillin (32, 35). PAG3 is
identical to KIAA0400 (36) and Pap
 
a
 
, which was identi-
fied as a Pyk2-binding protein (37). Our previous study us-
ing COS-7 cells revealed that PAG3 exhibits a GAP activ-
ity for ARF6 rather than ARF1 (32), although others have
shown that it exhibits phosphatidylinositol 4,5-bisphos-
phate–dependent GAP activity on ARF1 and ARF5 and
less activity on ARF6 in vitro (37). We report here that
PAG3 is colocalized with ARF6 and F-actin at phagocytic
cups formed beneath IgG-opsonized beads in mouse
P388D1 macrophage cells. We also found that ARF6, but
not ARF1 or ARF5, is involved in Fc
 
g
 
R-mediated phago-
cytosis in P388D1 macrophage cells, consistent with a pre-
vious report with RAW macrophage cells (10). These re-
sults prompted us to investigate whether PAG3 acts as a
GAP for ARF6 during Fc
 
g
 
R-mediated phagocytosis. To
do this, we also employed other ARFGAPs, G protein–
coupled receptor kinase interactor GIT2 and its spliced
variant, GIT2-short/KIAA0148 (38–41), as controls. GIT2
and GIT2-short also bind to paxillin, but with different af-
finities: GIT2 binds paxillin with a strong affinity, whereas
GIT2-short binds paxillin with a weak affinity (38). We
demonstrate that overexpression of PAG3, but not its
 
1
 
Abbreviations used in this paper: 
 
ARF, ADP-ribosylation factor; BFA,
brefeldin A; DIC, differential interference contrast; EGFP, enhanced
green fluorescent protein; GAP, GTPase-activating protein; HA, hemag-
glutinin; PAG, paxillin-associated protein with ARFGAP activity. 
957
 
Uchida et al.
 
GAP-inactive mutant or GIT2s, inhibits phagocytosis by
attenuating focal accumulation of F-actin and provides evi-
dence that PAG3 acts as a GAP for ARF6 during the
Fc
 
g
 
R-mediated phagocytosis of mouse P388D1 cells. Pos-
sible roles of PAG3 and its binding to paxillin and other
proteins in linking regulation between ARF and Rho fam-
ily GTPases during Fc
 
g
 
R-mediated phagocytosis are also
discussed.
 
Materials and Methods
 
Materials.
 
RPMI 1640, FCS, and 
 
b
 
-mercaptoethanol were
purchased from Life Technologies. Anti–influenza hemagglutinin
(HA) mAb was purchased from BAbCO, anti-ARF6 mAb was
from Santa Cruz Biotechnology, Inc., and Cy2-, Cy3-, Cy5-, or
horseradish peroxidase–conjugated secondary Abs were from
Jackson ImmunoResearch Laboratories. Unless indicated other-
wise, all other chemicals were obtained from Sigma-Aldrich or
Wako.
 
Cell Culture.
 
Mouse macrophage cell line P388D1 was a gift
from Y. Ito (Institute for Virus Research, Kyoto University).
Cells were maintained in RPMI 1640 supplemented with 10%
heat-inactivated FCS, 100 U/ml penicillin, 100 
 
m
 
g/ml strepto-
mycin, and 50 
 
m
 
M 
 
b
 
-mercaptoethanol at 37
 
8
 
C under 5% CO
 
2
 
 in
a humidified incubator.
 
Plasmids.
 
Wild-type PAG3 and its ARFGAP activity–defi-
cient mutant, C436A PAG3, cDNAs were subcloned into
pEGFP-C1 vector (CLONTECH Laboratories, Inc.) under the
control of the CMV promoter, as described previously (32).
cDNA of enhanced green fluorescent protein (EGFP)-tagged
PAG3 from pEGFP-PAG3 was subcloned into pBabePuro vector
(42) under the control of the murine retrovirus LTR promoter.
The HA epitope–tagged GIT2 and GIT2-short expression vec-
tors (pcDNA3/HA-GIT2 and pcDNA3/HA-GIT2-short) and
their ARFGAP activity–deficient C11A mutants (pcDNA3/HA-
GIT2CA and pcDNA3/HA-GIT2-shortCA) have been de-
scribed previously (38). cDNAs in pcDNA3 vectors, each encod-
ing ARF1-HA, ARF5-HA, ARF6-HA, and ARF6 Q67L-HA
(GTP hydrolysis–deficient mutant), were gifts from K. Nakayama
(Tsukuba University,
 
 Ibaraki
 
, Japan), and all have the HA tag at
their COOH terminals. pcDNA3 encoding ARF6 T27N-HA
(GTP binding–deficient mutant) was constructed as described
previously (12). Nucleotide sequences were confirmed for all the
plasmids after construction.
 
Transfection.
 
P388D1 cells (10
 
6
 
) were plated onto 35-mm
culture dishes (Becton Dickinson) and transfected 24 h later using
FuGENE6 (Boehringer) according to the manufacturer’s instruc-
tions. After transfection, cells were incubated overnight for 16–20 h
and then replated in 8-well glass chamber slides (Becton Dick-
inson) at a density of 10
 
4
 
 cells/well, and subjected to each assay
after further incubation for 16 h. For moderate expression, pBabe
vector, in which cDNA was transcribed from the murine retrovi-
rus LTR promoter, was used. For overexpression, pcDNA3 vec-
tor, pEGFP-C1 vector, or its derivatives were used, which con-
tain the CMV promoter. 2 
 
m
 
g of each plasmid was used per
35-mm culture dish. For cotransfection, 1.5 
 
m
 
g of pEGFP-
PAG3s was used together with 0.5 
 
m
 
g of pcDNA3/ARFs-HA, as
determined by preliminary titration experiments, unless otherwise
indicated.
 
Preparation of IgG-opsonized Beads.
 
Opsonized microspheres
were prepared as described previously (43). In brief, polystyrene
beads (3.0-
 
m
 
m diameter; Polysciences, Inc.) were washed twice
 
in PBS and incubated in 8% glutaraldehyde for 16 h. After incu-
bation with 0.1% BSA for 5 h, beads were washed in PBS and in-
cubated for 16 h in 0.5 M ethanolamine. Beads were incubated
with 0.2 mg/ml of rabbit polyclonal or mouse monoclonal anti-
BSA IgGs for 4 h. All incubations were performed at 25
 
8
 
C. Op-
sonized beads were washed twice in ice-cold PBS, resuspended in
RPMI 1640, and counted in a hemacytometer. Opsonization of
the IgG-coated beads was confirmed by positive and negative
counterstaining using Cy2-conjugated anti–rabbit IgG and Cy2-
conjugated anti–mouse IgG, respectively. Mouse IgG–opsonized
beads were used for the simultaneous detection of endogenous
PAG3, and rabbit IgG–opsonized beads were used for the other
experiments.
 
Phagocytosis Assay.
 
P388D1 cells transiently transfected with
the indicated constructs were placed in ice-cold medium contain-
ing IgG-opsonized beads at a concentration of 50 beads per target
cell. Cells were then incubated at 4
 
8
 
C for 20 min to allow attach-
ment of particles to cell surfaces, followed by incubation at 37
 
8
 
C
for 30 min, unless otherwise described, for particle internaliza-
tion. Cells were then washed in ice-cold HBSS to remove un-
bound beads. For staining attached but not internalized particles,
cells were incubated with Cy5-conjugated anti–rabbit IgG before
being permeabilized (10). The transfection-positive cells were
identified by staining the exogenous proteins (see below). Inter-
nalized particles in the transfection-positive cells were counted by
phase–contrast microscope. Attached but not internalized parti-
cles were identified as the Cy5
 
1
 
 staining. 50 cells expressing each
indicated construct and each of the 50 cells of the nonexpressing
control were scored for the attached and internalized beads. The
association index indicates the number of attached and internal-
ized beads per single cell. The phagocytosis index indicates the
number of internalized beads per single cell. The attachment in-
dex indicates the number of attached beads per single cell, after
incubation only at 4
 
8
 
C for 20 min. Data were expressed as an av-
erage (
 
6
 
 SE) of three independent experiments (a total of 150
transfection-positive cells were examined in each assay). The dif-
ference between transfectants and control cells was compared
with a Student’s 
 
t
 
 test. An asterisk denotes significant differences
between control cells (
 
P 
 
,
 
 0.001).
 
Immunofluorescence Characterization.
 
P388D1 cells and cells
transiently transfected with the indicated constructs were sub-
jected to phagocytosis assay as described above, then fixed in 4%
paraformaldehyde for 10 min at room temperature. After perme-
abilization with 0.1% Triton X-100 in PBS for 10 min at room
temperature, expressions of PAG3s, GIT2s, and ARFs were visu-
alized by immunostaining with appropriate Abs or detecting the
autofluorescence from the EGFP tag, as described previously (32,
38). Confocal images were acquired using a confocal laser scan-
ning microscope (model 510; Carl Zeiss, Inc.). Focus was ad-
justed across the center of the majority of phagocytic beads (
 
z
 
2–4
 
m
 
m above the surface of the glass chamber plates). Expression
levels of exogenous proteins were analyzed for each cell by quan-
tifying the intensities of the fluorescent signals using the com-
puter software associated with the confocal laser scanning micro-
scope (LSM 510 version 2.5; Carl Zeiss, Inc.). Nonspecific
background fluorescence levels were then determined by staining
the cells with irrelevant Abs coupled with the appropriate dye-
conjugated secondary Abs. Also, we confirmed beforehand that
the exogenous expression of proteins transcribed from the CMV
promoter (in pcDNA3 and pEGFP vectors) was at least 5–10-fold
higher than that from the LTR promoter (in pBabe
 
 
 
vector) in
most cells, and that the exogenous expression of proteins such as
PAG3 from the LTR was much the same or only slightly higher 
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than the endogenous expression seen in P388D1 cells. Each fig-
ure of microscopic analysis showed representative results that
were observed in a majority (
 
.
 
50–80%) of the transfected cells
from three independent experiments (
 
.
 
200 cells).
 
Immunoblotting.
 
P388D1 cells and cells transfected with the
indicated constructs were lysed on ice with 1% NP-40 buffer (1%
NP-40, 150 mM NaCl, 20 mM Tris-HCl, pH 7.4, 5 mM
EDTA, 1 mM Na
 
3
 
VO
 
4
 
, 10 
 
m
 
M Na
 
2
 
MoO
 
4
 
, 1 mM PMSF, 1%
aprotinin, 2 
 
m
 
g/ml leupeptin, 3 
 
m
 
g/ml pepstatin A) as described
previously (44). Protein concentrations were determined using a
Dc protein assay kit (Bio-Rad Laboratories) with BSA as a stan-
dard. Each 20 
 
m
 
g of protein was separated by SDS-PAGE and
transferred to a polyvinylidene difluoride membrane (Millipore).
Membranes were then incubated with mouse anti-HA mAb or
mouse anti-GFP mAb (CLONTECH Laboratories, Inc.), fol-
lowed by horseradish peroxidase–conjugated anti–mouse IgG.
Specific binding was detected using enzyme-linked chemilumi-
 
nescence, according to the manufacturer’s instructions (Amer-
sham Pharmacia Biotech). Each figure shows representative re-
sults from at least two independent experiments.
 
Cell Surface Fc
 
g
 
R Staining.
 
P388D1 cells were transfected us-
ing FuGENE6 with 2 
 
m
 
g of pEGFP-PAG3s or 2 
 
m
 
g of pEGFP-
C1 empty vector as a control. For HA-tagged proteins, each 1.8
 
m
 
g of pcDNA3 plasmid was cotransfected with 0.2 
 
m
 
g of
pEGFP-C1 empty vector as a marker. Only transfection-positive
cells, as detected by autofluorescence of the EGFPs (45, 46), were
then subjected to analysis of their surface expression of Fc
 
g
 
RII/
III. For analyzing Fc
 
g
 
RII/III expressions, transfected cells (10
 
6
 
)
were incubated with 5 
 
m
 
g/ml of PE-conjugated 2.4G2 mAb (BD
PharMingen) or isotype-matched irrelevant control Abs, in PBS
supplemented with 2% FCS and 0.01% sodium azide for 30 min
at 4
 
8
 
C. Cells were then washed three times in PBS, and fluores-
cence intensities were measured by a FACScan™ flow cytometer
(Becton Dickinson).
Figure 1. PAG3, but not GIT2s, accu-
mulates to phagocytic cups, together with
F-actin and ARF6. P388D1 cells and cells
transfected with pBabe/EGFP-PAG3,
pBabe/HA-GIT2-short, or pBabe/HA-
GIT2 were incubated with IgG-opsonized
beads for 20 min at 48C, and fixed after in-
cubation at 378C for 5 min. (A) Endoge-
nous PAG3 (panel a) was visualized using an
anti-PAG3 Ab coupled with Cy2-anti–rab-
bit IgG, and EGFP-PAG3 (panel e), HA-
GIT2-short (panel i), and HA-GIT2 (panel
m) were visualized by detecting the auto-
fluorescence from the EGFP, or by staining
cells with an anti-HA mAb coupled with
Cy2-anti–mouse IgG. F-actin was visual-
ized with Texas red X–conjugated phalloi-
din (panels b, f, j, and n). The third panels
represent the merging of the left two panels.
The right panels show the differential inter-
ference contrast (DIC) images of the same
fields of the three preceding panels. Arrows
indicate positions of phagocytic beads. The
expression levels of EGFP-PAG3 in each
cell were almost equal or only slightly
higher compared with the levels of en-
dogenous PAG3, as assessed by staining
EGFP-PAG3–expressing cells with an anti-
PAG3 Ab, coupled with Cy3-anti–rabbit
IgG, and comparing their fluorescent signals
with those of untransfected cells (the trans-
fected cells gave 2.4 6 0.1–fold higher sig-
nals than the untransfected cells; see Materi-
als and Methods). (B) EGFP-PAG3 (panel
a) and F-actin (panel c) were visualized as
above; endogenous ARF6 was detected us-
ing anti-ARF6 mAb coupled with Cy5-
anti–mouse IgG (panel b). Panel d repre-
sents the merging of panels a–c, and panel e
shows the DIC images of the same fields of
panels a–d. Higher magnifications of images
of panels a–d (indicated by rectangles) are
each shown below (panels f–i). Bars, 5 mm. 
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Results
 
PAG3 Accumulates in Phagocytic Cups Together with F-Actin
and ARF6.
 
We have shown that an ARFGAP, PAG3, is
expressed in human mature monocyte and macrophage-
like cells, is localized at the cell periphery, and acts as a
GAP for ARF6 in COS-7 cells (32). ARF6 has been
shown to be involved in the Fc
 
g
 
R-mediated phagocytosis
in macrophages (10). Therefore, we examined a possible
role of PAG3 in the Fc
 
g
 
R-mediated phagocytosis in mac-
rophages in this study.
First, we investigated the subcellular localization of
PAG3 in phagocytic macrophage cells. P388D1 mouse
macrophages were briefly incubated at 37
 
8
 
C with IgG-
opsonized beads, fixed, and stained for endogenous PAG3
and actin filaments. As shown in Fig. 1 A, PAG3 was found
to accumulate at the phagocytic cups formed beneath the
 
IgG-opsonized beads, and was seen to largely, but not
completely, overlap with F-actin. Next we examined
whether PAG3 colocalized with ARF6 at the phagocytic
cups. For this purpose, an EGFP-tagged PAG3 was used,
since the opsonized beads used for this assay had already
been coated with rabbit or mouse IgG, and we only have
access to rabbit IgG for PAG3 and mouse IgG for ARF6.
EGFP-PAG3 was expressed from the pBabe vector to en-
sure only moderate levels of expression to avoid possible
effects attributable to its overexpression (see Materials and
Methods). We have previously confirmed that PAG3 can
be tagged with EGFP without significant biological alter-
ation, retaining its subcellular localization (32). Accumula-
tion of EGFP-PAG3 was then clearly detected at the phago-
cytic cups, together with ARF6 and F-actin (Fig. 1 B).
Figure 2. Effects of overexpression of ARF isoforms on FcgR-
mediated phagocytosis. (A) Phagocytic activities of P388D1 cells
against IgG-opsonized and nonopsonized polystyrene beads.
P388D1 cells, preincubated with (1) or without (2) anti–mouse
FcgRII/III mAb 2.4G2 for 30 min at 48C, were incubated with
polystyrene beads nonopsonized or opsonized with rabbit IgG for
20 min at 48C, followed by 30 min at 378C. After removal of un-
bound beads, the number of beads attached and ingested per single
cell (the association index) was counted as described in Materials and
Methods. (B and C) Inhibition of FcgR-mediated phagocytosis by
overexpression of the class III ARF (ARF6), but not other classes of
ARFs. P388D1 cells transiently transfected with the indicated con-
structs in pcDNA3 vectors were incubated with IgG-opsonized
beads as above. Each ARF cDNA was tagged with HA tag. The
number of beads ingested per single cell (the phagocytosis index)
was determined for cells expressing the indicated constructs and for
nonexpressing controls (MOCK), as described in Materials and
Methods. Wild-type cDNAs of ARF1, ARF5, and ARF6 were
used in B, and wild-type and Q67L and T27N mutants of ARF6
were used in C. The exogenous expression of HA-tagged ARFs, as
detected by immunoblotting using anti-HA mAb, is shown below.
The expression levels of exogenous wild-type ARF6-HA were
8.1 6 0.5–fold higher than endogenous ARF6. This estimation was
obtained by immunostaining the mock-transfected cells and cells
expressing ARF6-HA using an anti-ARF6 mAb coupled with Cy3-
anti–mouse IgG, and differences in fluorescent intensities of single
cells in these two samples were compared as described in Materials
and Methods. Abs that specifically recognize ARF1 or ARF5 were
not available. (D and E) Overexpression of ARF isoforms does not
affect the binding to IgG-opsonized beads and surface expression of
FcgRs. Binding to IgG-opsonized beads was assessed by incubating
cells with the beads for 20 min at 48C. Unbound beads were then
removed by washing, and numbers of beads attached to the trans-
fected cells are shown (the attachment index) (D). Other procedures
are as described above. (E) Surface levels of FcgRs on cells tran-
siently transfected with the indicated ARF cDNA constructs and,
hence, expressing the exogenous proteins were assessed by staining
the nonpermeabilized cells with 2.4G2 mAb (solid line; see Materi-
als and Methods). Control uses irrelevant rat IgG (broken line). In
A–D, data are expressed as the mean 6 SE of three independent ex-
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To assess the specificity of PAG3 localization to the
phagocytic cups, we employed two other ubiquitously ex-
pressed ARFGAPs, GIT2 and its short isoform, GIT2-
short/KIAA0148 (38–41). Like PAG3, both GIT2 and
GIT2-short are able to bind to paxillin, although their af-
finities differ significantly (38). Because Abs raised against
the GIT2 proteins were weak for immunostaining, we ex-
pressed the HA-tagged cDNAs that were also constructed
in the pBabe vector to ensure moderate levels of expres-
sion. As shown in Fig. 1 A, HA-GIT2 and HA-GIT2-short
did not accumulate at the phagocytic cups, unlike in the
case of PAG3.
It has been shown that simple overexpression of wild-
type ARF6 blocks FcgR-mediated phagocytosis in RAW
cells (10). It has also been demonstrated that ARF isoforms
whose activities are influenced by BFA may not be essential
for the phagocytosis (10). Therefore, we examined whether
or not each class of ARF isoforms participates in the phago-
cytic activities in our experimental system. The HA-tagged
ARF isoforms were overexpressed using the CMV pro-
moter of the pcDNA3 vector, and expression levels of the
HA-tagged ARFs in each cell were examined using confo-
cal laser scanning microscopy and its attached computer
software, before data acquisition (see Materials and Meth-
ods). ARF1 was used to represent class I and ARF5 was
used to represent class II. As shown in Fig. 2 B, transient
overexpression of wild-type ARF6-HA reduced the num-
ber of IgG-opsonized beads ingested by the transfected
cells, as has been shown with RAW cells (10). In contrast,
transient overexpression of ARF1-HA and ARF5-HA,
which were expressed at similar levels to ARF6-HA, did
not exert such inhibitory effects on phagocytosis (Fig. 2 B).
Unlike other small GTPases such as the Rho and Ras
family members, it has been well documented that both the
GTP hydrolysis–deficient and the GTP binding–deficient
mutants of ARF proteins are able to exhibit inhibitory ef-
fects on the trafficking and recycling of cell surface recep-
tors (10, 17). Similarly, blockage of FcgR-mediated phago-
cytosis was also observed in the transient overexpression of
both the GTP hydrolysis–deficient (Q67L) and the GTP
binding–deficient (T27N) mutants of ARF6 in our system
(Fig. 2 C), again similar to those reported previously with
RAW cells (10).
On the other hand, the binding ability of FcgRs to the
IgG-opsonized beads, as assessed by incubating macro-
phages with the test beads only at 48C, was not significantly
affected by overexpression of these proteins, including
ARF6 mutants (Q67L and T27N) (Fig. 2 D; data not
shown). Surface expression of FcgRs, as assessed by stain-
ing cells with anti–mouse FcgRII/III mAb 2.4G2 was also
almost unaffected by these proteins (Fig. 2 E). We also
confirmed that P388D1 cells did not exhibit significant
phagocytic activity towards nonopsonized polystyrene beads,
and that phagocytosis of the IgG-coated beads in P388D1
cells was substantially inhibited by preincubation of the
cells with anti-FcgRII/III mAb 2.4G2 (Fig. 2 A), as has
been shown previously with other macrophage cells (47).
Overexpression of PAG3, but Not Its GAP-inactive Mutant
or GIT2s, Inhibits FcgR-mediated Phagocytosis. Next we
examined whether PAG3 is involved in FcgR-mediated
Figure 3. Overexpression of PAG3, but not its GAP-
inactive mutant or GIT2s, inhibits FcgR-mediated
phagocytosis. (A and B) P388D1 cells (MOCK) and cells
transiently transfected with the empty pEGFP-C1 vector
(Vec), or the plasmids containing cDNAs for wild-types
(WT) or the GAP-inactive mutants (CA) of EGFP-
PAG3, HA-GIT2, and HA-GIT2-short, were incubated
with IgG-opsonized beads for 20 min at 48C, followed
by 30 min at 378C to define the phagocytosis index (A);
or only for 20 min at 48C to define the attachment index
(B). Cells expressing the exogenous proteins were exam-
ined as described in Materials and Methods. Data are
expressed as the mean 6 SE of three independent exper-
iments.  *P  ,  0.001. The exogenous expression of
HA-tagged GIT2s, EGFP-tagged PAG3s and EGFP, de-
tected by immunoblotting using anti-HA mAb and anti-
GFP mAb, is shown in A. (C) Equivalent expression of
FcgRs on cells transiently transfected with the indicated
constructs was demonstrated by flow cytometry analysis.
Surface levels of FcgRs of only transfection-positive cells
were assessed as in the legend to Fig. 2. 2.4G2 staining
(solid line) and rat IgG control (broken line) are shown.
Mock-transfected cells without plasmid DNA were also
included as a control. Overexpression of EGFP-PAG3
was confirmed by immunostaining of the mock-trans-
fected cells and cells expressing EGFP-PAG3 with poly-
clonal anti-PAG3 Abs coupled with Cy3-anti–rabbit
IgG, and differences in fluorescent intensities of single
cells from these two samples were compared as in the
legend to Fig. 2. The level of overexpression of EGFP-
PAG3 was estimated to be 23.7 6 1.1–fold higher than
that of endogenous PAG3.961 Uchida et al.
phagocytosis. Although our previous study indicates that
PAG3 can act as a GAP for ARF6 in COS-7 cells (32), it
has been proposed that different GAPs may be involved in
the recruitment of different coatomer proteins to the same
ARF (48). Therefore, we investigated whether PAG3 acts
on ARF6 during FcgR-mediated phagocytosis in mac-
rophages.
It has been shown previously that the overexpression of
ARFGAPs, but not their GAP-inactive mutants, are able to
act in an inhibitory manner towards ARF functions in sev-
eral assay systems (32, 38). Therefore, PAG3 and GIT2s
were overexpressed at high levels using the CMV promoter
in P388D1 cells. As shown in Fig. 3 A, overexpression of
EGFP-PAG3 inhibited phagocytosis of IgG-opsonized
beads. In contrast, such inhibition was not observed by the
GAP-inactive CA mutant of EGFP-PAG3, nor by HA-
GIT2, HA-GIT2-short, and their GAP-inactive CA mu-
tants, although they were all overexpressed at similar levels
(Fig. 3 A). Again, surface expression of the FcgRII/III and
the ability to bind opsonized beads were not significantly
altered by the overexpression of these proteins, including
wild-type EGFP-PAG3 (Fig. 3, B and C).
Overexpression of PAG3 Affects Actin–Cytoskeletal Remod-
eling. ARF6 has been shown to be involved in actin rear-
rangements in HeLa and Chinese hamster ovary cells (18,
21–25), and also in the phagocytosis of particles in RAW
cells (10). Consistent with the notion that PAG3 acts as a
GAP for ARF6 in the phagocytosis, we found that overex-
pression of EGFP-PAG3, but not its GAP-inactive mutant,
attenuated the focal accumulation of F-actin beneath IgG-
opsonized particles and inhibited phagocytic cup formation
(Fig. 4 A), though cells overexpressing EGFP-PAG3 could
bind to the test beads almost normally, as already described
in Fig. 3 B (see also Fig. 4 A). On the other hand, overex-
pression of HA-GIT2 and HA-GIT2-short did not affect
the focal accumulation of F-actin and phagocytic cup for-
mation (Fig. 4 A), again supporting the distinct and specific
function of PAG3 in the FcgR-mediated phagocytosis.
The GAP-inactive mutants of GIT2s were also ineffective
(data not shown). In these experiments, a significant pro-
Figure 4. Overexpression of
PAG3, but not its GAP-inactive
mutant or GIT2s, attenuates the fo-
cal accumulation of F-actin beneath
IgG-opsonized beads and its restora-
tion by cooverexpression of ARF6.
P388D1 cells and cells transiently
transfected with the indicated plas-
mid constructs were incubated with
IgG-opsonized beads and processed
for laser confocal microscopic analy-
sis, as described in the legend to Fig.
1, except that HA-tagged ARF6 was
visualized with anti-HA mAb cou-
pled with Cy5-anti–mouse IgG. All
plasmid constructs were derived
from pcDNA3 or pEGFP, and the
overexpression of exogenous pro-
teins was confirmed as in the legends
to Figs. 2 and 3. (A) Cells were
mock-transfected (MOCK; panels
a–e), or transfected with plasmid
DNAs for wild-type EGFP-PAG3
(panels f–j), its GAP-inactive mutant
(panels k–o), wild-type HA-GIT2-
short (panels p–t), and wild-type
HA-GIT2 (panels u–y). Exogenous
ARFGAP proteins (panels a, f, k, p,
and u) and F-actin (panels b, g, l, q,
and v) were visualized as described
in the legend to Fig. 1. The third
column of panels (c, h, m, r, and w)
represent the merging of the first
two columns of panels, and their
higher magnifications are shown in
the fourth column of panels (indi-
cated by rectangles; panels d, i, n, s,
and x). The last column of panels (e,
j, o, t, and y) show the DIC images
of the same fields of the left four
panels. (B) Cells were cotransfected
with 1.5 mg of plasmid DNA for
wild-type EGFP-PAG3 together with 0.5 mg of plasmid DNA for ARF6-HA; and EGFP-PAG3 (panel a), ARF6-HA (panel b), and F-actin (panel c)
were visualized as above (see also the legend to Fig. 5 C, third column). Panel d represents the merging of the three left panels. Panel e shows the DIC
image of the same field of the first four panels. Arrows indicate the position of phagocytic beads. Bars, 5 mm.962 PAG3 Regulates ADP-Ribosylation Factor 6 in Macrophage Phagocytosis
portion of the EGFP-PAG3 CA mutant, and also a small
proportion of HA-GIT2, could be detected at the phago-
cytic cups. Since these proteins were overexpressed at high
levels in the cytosol, we do not know whether these local-
izations imply some sort of biological significance.
Overexpression of ARF6, but Not ARF1 or ARF5, Can
Restore the PAG3-induced Inhibition of FcgR-mediated Phago-
cytosis. Finally, to verify the functional relationship be-
tween PAG3 and ARF6, we examined whether overexpres-
sion of ARF6 could restore the inhibition of FcgR-mediated
phagocytosis induced by the overexpression of PAG3, and
vice versa. Unlike other Ras superfamily small GTPases,
ARFs do not exhibit detectable intrinsic GTPase activities
(11). Therefore, ARFs appear to primarily depend on
ARFGAPs for hydrolyzing bound GTP, and the molecular
ratio between ARFs and their GAPs may be important for
biological functions of ARF molecules.
Plasmid DNA for PAG3 was cotransfected with plasmid
DNA for ARF isoforms, where all plasmids were designed
for the overexpression. As shown in Fig. 5 C, we found
that increasing amounts of plasmid for EGFP-PAG3 to-
gether with decreasing amounts of plasmid for ARF6-HA
gave bell-shaped dose responses of the phagocytosis index,
and a condition was found where both EGFP-PAG3 and
ARF6-HA were overexpressed but the phagocytic activity
of the transfected cells was restored to almost normal. In
contrast, a control experiment using the GAP-inactive mu-
tant of EGFP-PAG3, instead of wild-type EGFP-PAG3,
did not give such bell-shaped dose responses, but gave re-
sponses declining linearly in accordance with amounts of
ARF6-HA plasmid DNA transfected (Fig. 5 C). Coover-
expression of EGFP-PAG3 with the Q67L or the T27N
mutant of ARF6-HA was also unable to restore phagocytic
activity (Fig. 5 C). Moreover, such conditions for the ap-
parent restoration of the phagocytosis index were found
neither with cooverexpression of EGFP-PAG3 and ARF1-
HA nor with cooverexpression of EGFP-PAG3 and
ARF5-HA (Fig. 5, A and B), although we examined with
several different ratios between PAG3 and these ARF iso-
forms in addition to those shown in Fig. 5 (data not
shown). These results again are consistent with a notion
that PAG3 acts as a GAP for the class III ARF, ARF6, but
not other classes of ARFs, and is thereby involved in the
FcgR-mediated phagocytosis in macrophages. Accumula-
tion of F-actin beneath the IgG-opsonized beads was also
observed in cells overexpressing both EGFP-PAG3 and
ARF6-HA, where their phagocytic activities were restored
to almost normal (Fig. 4 B).
Discussion
In this study, we have demonstrated that PAG3 is in-
volved in FcgR-mediated phagocytosis in macrophages
and provided evidence for the first time that PAG3 acts as a
GAP for ARF6 during phagocytosis. We have also shown
that endogenous PAG3 accumulates at phagocytic cups to-
gether with ARF6 and F-actin, and on the other hand, its
overexpression attenuates the focal accumulation of F-actin
beneath IgG-opsonized beads and blocks phagocytosis.
FcgR-mediated phagocytic activity of macrophages is es-
sential for the immune response and for inflammation, and
also participates in development and tissue remodeling (1,
2). It has also been implicated in several noninfectious dis-
eases such as rheumatoid arthritis and atherosclerosis (49–
51). Moreover, there are striking similarities in the pro-
cesses for the remodeling of cytoskeletal architecture and
Figure 5. Cooverexpression of ARF6, but not other classes of ARF isoforms, restores the PAG3-induced inhibition of FcgR-mediated phagocytosis.
P388D1 cells and cells transiently transfected with the indicated plasmid constructs in pEGFP and pcDNA3 vectors for overexpression were incubated
with IgG-opsonized beads, and the phagocytosis index was determined, as described in the legend to Fig. 2. Plasmid DNAs for EGFP-PAG3 (WT) or its
GAP-inactive mutant (CA) were cotransfected with plasmid DNAs for ARF1-HA (A), ARF5-HA (B), and ARF6-HA (C). In A–C, 2.0 mg of plasmid
DNA for EGFP-PAG3 (bar 2), 1.5 mg of plasmid DNA for EGFP-PAG3 plus 0.5 mg of plasmid DNA for each ARF-HA (bar 3), and 2.0 mg of plasmid
DNA for each ARF-HA (bar 4) were used; the GAP-inactive mutant of EGFP-PAG3 was used instead of wild-type EGFP-PAG3 in bars 5–7, as indi-
cated. In bars 8 and 9 in C, 1.5 mg of plasmid DNA for EGFP-PAG3 plus 0.5 mg of plasmid DNA for the Q67L mutant (bar 8) or the T27N mutant (bar
9) of ARF6-HA were used. Mock-transfected controls were also included (bar 1 in A–C). The overexpression of exogenous proteins were confirmed as
described in the legend to Figs. 2 and 3, with each cell examined for the phagocytic activities. In bar 3 in C, these cells expressed EGFP-PAG3 at levels
25–30-fold higher than endogenous PAG3, and expressed ARF6-HA at levels 7–9-fold higher than endogenous ARF6 (also see Fig. 4 B). In bars 2 and 4
in C, the expression levels of EGFP-PAG3 and ARF6-HA were essentially the same as those described in the legend to Figs. 2 and 3. Expression of ARF1-
HA and ARF5-HA in A and B was also similar to those in Fig. 2. Data are expressed as the mean 6 SE of three independent experiments. *P , 0.001.963 Uchida et al.
membrane structure between the extension of pseudopods
during phagocytosis and the formation of leading edges
during cell migration (52); the latter has been also our in-
quiry with PAG3 (32; also see below).
One of our major concerns in this study is the specificity
of PAG3 for ARF isoforms. We have previously shown
that PAG3 acts as a GAP for ARF6, rather than ARF1, in
COS-7 cells (32), where each class of ARF isoforms was
overexpressed and subjected to activation by treating the
cells briefly with AlF (a mixture of 30 mM NaF and 50 mM
AlCl3; reference 18), an activator of heterotrimeric G pro-
teins (24, 25). However, results obtained from in vitro as-
says regarding the specificity of PAG3 for different ARF
isoforms (37) were contradictory to our in vivo results, as
mentioned above. Moreover, it has been suggested that dif-
ferent GAPs may be involved in the recruitment of differ-
ent coatomer proteins to the same ARF (48). We therefore
tested whether PAG3 acts as a GAP for ARF6 during
FcgR-mediated phagocytosis in macrophages, in which
ARF6 has been shown to play a role (10). We showed that
PAG3 localizes and accumulates at the phagocytic cups
formed beneath IgG-opsonized beads, and that overexpres-
sion of PAG3, but not its GAP-inactive mutant, is inhibi-
tory for the phagocytic activity. Thus, we examined which
class(es) of ARF isoforms is the target of PAG3 during
macrophage phagocytosis. Our results indicated that PAG3
acts on the class III ARF, ARF6, but not on the class I
ARF, ARF1, or on the class II ARF, ARF5, during FcgR-
mediated phagocytosis. We also employed other ubiq-
uitously expressed ARFGAPs, GIT2 and its isoform
GIT2-short (38–41), and showed that these proteins nei-
ther accumulate at the phagocytic cups when expressed at
moderate levels nor inhibit the phagocytic activity even
when overexpressed. Again, although our in vivo assays in
COS-7 cells indicated that both GIT2 (unpublished results)
and GIT2-short (38) exhibit GAP activities for ARF1, but
not for ARF6, these proteins have been shown to exhibit
similar GAP activities toward different classes of ARF iso-
forms in vitro, including ARF1, 2, 4, and 6, which was
conducted in the absence of coatomers or effectors (40,
41). Our results here are again consistent with our previous
results, and GIT2 and GIT2-short do not appear to exhibit
efficient GAP activities for ARF6 during FcgR-mediated
phagocytosis in macrophages. A possible reason for the dis-
crepancy in the specificities of ARFGAPs measured in vivo
and in vitro has already been discussed (32, 38).
We showed here that overexpression of PAG3 attenu-
ates the focal accumulation of F-actin. Phagocytosis pro-
ceeds in discrete but coordinated stages, in which both the
actin-based cytoskeletal remodeling and the membrane re-
modeling take place (1, 2). Actin-based cytoskeletal re-
modeling is primarily regulated by Rho family GTPases
(7–9), and several downstream effectors of these GTPases
have been identified (8). Some of the effector proteins,
such as the Arp2/3 complex, have been shown to function
in macrophages to regulate phagocytosis (8). On the other
hand, membrane remodeling is the major role for ARF
family GTPases (12, 13, 16). Although several ARF family
GTPases, including ARF6, have been shown to participate
also in actin cytoskeletal remodeling (18, 22–25, 28, and
this study), molecular mechanisms by which ARFs regu-
late actin cytoskeleton are still largely unknown. In this re-
gard, it has been recently shown that Rho and ARF family
GTPases intercommunicate with each other to determine
actin–cytoskeletal architecture (22–25, 28, 29). Hence,
some mechanism must exist that links the regulation of
these two different families of GTPases, temporally and
spatially. This putative linkage may also be important for
coordination of the actin-based cytoskeletal remodeling
and the membrane remodeling. Lipid modification of the
plasma membrane is likely to be involved. For example,
Rho family GTPases each contain different lipid modifica-
tion (53), and several proteins regulating Rho and ARF
family GTPases also contain different pleckstrin homology
domains, which could interact differently with the plasma
membrane, depending on the lipid composition (54).
Moreover, several enzymes that modify membrane lipids
act downstream of these GTPases (55, 56). On the other
hand, it is also possible that some proteins physically bridge
Rho and ARF family GTPases and/or proteins regulating
these GTPases. POR1, partner of Rac1, exhibits a poten-
tial for interacting with both Rac1 and ARF6 in vitro (57,
58), though its physiological relevance has not yet been
clarified (23). PAG3 contains several different protein–pro-
tein interaction modules including a zinc finger motif,
ankyrin repeats, proline-rich sequences, and a src homol-
ogy 3 domain, and also contains a pleckstrin homology do-
main (32, 37). PAG3 binds to paxillin (32), which is local-
ized to FcgR-mediated phagocytic cups (33, 34). It has
been shown that paxillin can associate with a p21-activated
kinase (PAK)-interacting guanine nucleotide exchanger b
called bPIX (59, 60), a guanine nucleotide exchanging fac-
tor for Rac1 (61). We also found that paxillin can directly
bind to a Rac/Cdc42 downstream effector kinase PAK3
(60), though these two proteins have been previously pro-
posed to be indirectly associated (59). Moreover, we found
that PAG3 binds directly to amphiphysin IIm (unpublished
results), which is a macrophage-specific amphiphysin II
isoform and required for FcgR-mediated phagocytosis in
murine resident peritoneal macrophages by recruiting a
GTPase, dynamin, to the nascent phagosome (46). Fur-
thermore, it should be noted that PAG3 was identified also
as a binding protein to a protein tyrosine kinase, Pyk2 (37),
which has been shown to participate in FcgRIIA/IIIB-
mediated phagocytosis in human neutrophils (62). There-
fore, PAG3 has the potential to serve to coordinate the
regulation of different families of GTPases in FcgR-medi-
ated phagocytosis, including Rho and ARF family GTP-
ases and dynamin, and may also be involved in the co-
ordination of activities of these GTPases with signal
transduction events of protein tyrosine phosphorylation.
However, the biological relevance of these hypotheses
largely remains to be examined.
Macrophage phagocytosis provides an excellent model
system for understanding the mechanism for the coordina-
tion of actin-based motility, membrane/vesicular traffick-964 PAG3 Regulates ADP-Ribosylation Factor 6 in Macrophage Phagocytosis
ing, and signal transduction (1, 2). Identification of PAG3,
which exhibits a multiple protein–protein interaction prop-
erty, as a GAP for ARF6 in macrophage FcgR-mediated
phagocytosis will thus provide a way for the further under-
standing of the fine mechanisms for this complicated and
fundamental model system.
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